tazobactam has been researched along with Blood Poisoning in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (3.45) | 18.2507 |
2000's | 6 (20.69) | 29.6817 |
2010's | 15 (51.72) | 24.3611 |
2020's | 7 (24.14) | 2.80 |
Authors | Studies |
---|---|
Akazawa, N; Itoh, N; Kuwahara, T; Yanaidani, T | 1 |
Bauer, SR; Campbell, MJ; Dettmer, MR; Erickson, RM; Fertel, BS; Sacha, GL; Wesolek, JL | 1 |
Colman, R; De Cock, PA; De Paepe, P; Devreese, M; Dhont, E; Hermans, E; Vande Walle, J; Verougstraete, N; Zeitlinger, M | 1 |
Flamm, RK; Pfaller, MA; Shortridge, D; Streit, JM | 1 |
Adams, R; Agus, A; Barnes, RA; Chau, I; Clarke, M; Coyle, V; Doran, A; Forde, C; Grayson, M; McAuley, DF; McDowell, C; McMullan, R; Plummer, R; Thomas, AL; Wilson, RH | 1 |
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A | 1 |
Chatfield, MD; Harris, PNA; Littleford, R; Paterson, DL; Stewart, AG | 1 |
Mueller, BA; Shaw, AR | 1 |
Goodlet, KJ; Nailor, MD; Nicolau, DP | 1 |
Coburn, B; Daneman, N; MacFadden, DR | 1 |
Kollef, MH; Micek, ST; Vazquez Guillamet, MC; Vazquez, R | 1 |
Cipelli, R; Dangoor, A; Hodgson, M; Lester, JF; Naik, J; Newsom-Davis, T; Patel, A; Shah, R; Summerhayes, M; Talbot, D; Talbot, T | 1 |
Colby, J; Fissell, WH; Groszek, JJ; Patel, P; Seegmiller, A; Shotwell, M; Verhoven, SM; Verstraete, A | 1 |
Boots, RJ; Jarrett, P; Kirkpatrick, CM; Lipman, J; Roberts, JA; Varghese, JM | 1 |
Baek, JY; Sohn, KM | 1 |
Geerlings, SE; Holleman, F; Schneeberger, C | 1 |
De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X | 1 |
Subaalaxmi, MV | 1 |
Braun, L; Fairchok, M; Flanagan, R; Mahlen, S; Sainato, R | 1 |
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F | 1 |
Chai, LY; Chee, YL; Chng, WJ; Ding, Y; Hsu, LY; Jin, J; Lee, YM; Poon, LM; Tan, LK | 1 |
Hoppe, UC; Kochanek, M; Larbig, R; Lehman, C; Michels, G; Reda, S; Rottländer, D | 1 |
Deng, S; Han, C; Li, X; Liao, Z; Wang, W; Xu, W | 1 |
Dittrich, P; Maier, A; Matzi, V; Nuhsbaumer, S; Pinter, H; Pinter, J; Smolle, J; Smolle-Jüttner, FM; Tomaselli, F; Woltsche, M | 1 |
Hameed, S; Johnson, M; Lipman, M; Tariq, S; Tyrer, M | 1 |
Marinella, MA | 1 |
Harada, AS; Lau, W | 1 |
Chow, P; Godambe, S; Maulidi, H | 1 |
Klimonova, NV; Lobakov, AI; Nasonov, VN; Savitskaia, KI; Savov, AM | 1 |
4 review(s) available for tazobactam and Blood Poisoning
Article | Year |
---|---|
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam | 2020 |
Antibiotic Dosing in Continuous Renal Replacement Therapy.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Critical Illness; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Renal Replacement Therapy; Sepsis; Tazobactam; Thienamycins | 2017 |
Delftia lacustris septicemia in a pheochromocytoma patient: case report and literature review.
Topics: Adrenal Gland Neoplasms; Aged; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Delftia; DNA, Bacterial; DNA, Ribosomal; Gram-Negative Bacterial Infections; Humans; Male; Penicillanic Acid; Pheochromocytoma; Piperacillin; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, DNA; Tazobactam | 2015 |
Febrile urinary tract infections: pyelonephritis and urosepsis.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Diabetes Complications; Fever; Humans; Immunocompromised Host; Levofloxacin; Penicillanic Acid; Pyelonephritis; Randomized Controlled Trials as Topic; Risk Factors; Sepsis; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2016 |
4 trial(s) available for tazobactam and Blood Poisoning
Article | Year |
---|---|
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Cost-Benefit Analysis; Drug Administration Schedule; Equivalence Trials as Topic; Humans; Meropenem; Multicenter Studies as Topic; Neoplasms; Neutropenia; Piperacillin; Pragmatic Clinical Trials as Topic; Quality of Life; Sepsis; Tazobactam; Treatment Outcome | 2020 |
Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferior
Topics: Adult; Anti-Bacterial Agents; Australia; beta-Lactamases; Cephalosporins; Clostridioides difficile; Escherichia coli; Humans; Italy; Lebanon; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Saudi Arabia; Sepsis; Singapore; Spain; Tazobactam | 2021 |
[A multicenter clinical trial of piperacillin/tazobactam in burn infection].
Topics: Adult; Burns; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Treatment Outcome | 2002 |
[Use of piperacillin-tazobactam in abdominal surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Sepsis; Surgical Wound Infection; Tazobactam; Treatment Outcome | 1997 |
21 other study(ies) available for tazobactam and Blood Poisoning
Article | Year |
---|---|
Clinical and microbiological features of intratumor abscess with bloodstream infection caused by Plesiomonas shigelloides, Citrobacter freundii, Streptococcus mitis/oralis, Clostridium perfringens, and Candida albicans in a patient with cholangiocarcinoma
Topics: Abscess; Aged; Antifungal Agents; Bacteremia; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Candida albicans; Cholangiocarcinoma; Citrobacter freundii; Clostridium perfringens; Humans; Levofloxacin; Male; Piperacillin; Plesiomonas; RNA, Ribosomal, 16S; Sepsis; Soil; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptococcus mitis; Streptococcus oralis; Tazobactam | 2022 |
Association between emergency department sepsis order set design and delay to second dose piperacillin-tazobactam administration.
Topics: Adult; Anti-Bacterial Agents; Emergency Service, Hospital; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Tazobactam | 2023 |
Microdialysis as a safe and feasible method to study target-site piperacillin-tazobactam disposition in septic piglets and children.
Topics: Animals; Anti-Bacterial Agents; Child; Humans; Microdialysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Swine; Tazobactam | 2023 |
Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.
Topics: Asia; Cephalosporins; Europe; Female; Global Health; Humans; Latin America; Male; Microbial Sensitivity Tests; North America; Pacific Islands; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Public Health Surveillance; Sepsis; Skin Diseases, Bacterial; Tazobactam | 2020 |
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin | 2017 |
Optimizing Empiric Antibiotic Selection in Sepsis: Turning Probabilities Into Practice.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Gram-Negative Bacteria; Humans; Meropenem; Probability; Sepsis; Tazobactam | 2018 |
Reply to MacFadden et al.
Topics: Bacteremia; Cefepime; Gram-Negative Bacteria; Humans; Meropenem; Piperacillin; Sepsis; Tazobactam | 2018 |
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Retrospective Studies; Sepsis; Taxoids; Tazobactam | 2017 |
Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
Topics: Blood Specimen Collection; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Monitoring; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Tazobactam | 2018 |
Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Critical Illness; Extracellular Fluid; Female; Half-Life; Hemofiltration; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Tazobactam | 2014 |
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Shock, Septic; Tazobactam; Thienamycins | 2010 |
Septicemic melioidosis.
Topics: Humans; Male; Melioidosis; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Time Factors; Treatment Outcome | 2010 |
Severe human parechovirus sepsis beyond the neonatal period.
Topics: Anti-Bacterial Agents; Blood Coagulation Disorders; Ceftriaxone; Enterocolitis, Necrotizing; Enzyme Inhibitors; Fever; Heart Failure; Hepatitis; Humans; Infant; Male; Parechovirus; Penicillanic Acid; Picornaviridae Infections; Piperacillin; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sepsis; Sequence Analysis, RNA; Tazobactam | 2011 |
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult | 2013 |
Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
Topics: Academic Medical Centers; Adult; Bacteremia; Carbapenems; Ceftazidime; Drug Resistance, Multiple; Febrile Neutropenia; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prevalence; Prospective Studies; Risk Factors; Sepsis; Singapore; Tazobactam; Treatment Outcome; Universities | 2012 |
[Systemic hantavirus-infection in a comatose HIV patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Coma; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Hemorrhagic Fever with Renal Syndrome; Hepatitis B, Chronic; Humans; Male; Penicillanic Acid; Piperacillin; Puumala virus; Respiratory Distress Syndrome; Sepsis; Tazobactam | 2013 |
Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
Topics: Adult; Aged; Area Under Curve; Enzyme Inhibitors; Female; Humans; Lung; Male; Microdialysis; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Sepsis; Tazobactam | 2003 |
Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Gentamicins; Glucocorticoids; HIV Infections; Humans; Lymphocyte Count; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Respiration, Artificial; Sepsis; Skin Diseases; Tazobactam; Treatment Outcome | 2005 |
Group C streptococcal sepsis complicating Fournier gangrene.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Debridement; Diabetes Mellitus, Type 2; Drug Combinations; Fournier Gangrene; Humans; Male; Penicillanic Acid; Perineum; Piperacillin; Scrotum; Sepsis; Streptococcal Infections; Tazobactam | 2005 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Suspected drug reaction with piperacillin/tazobactam, in a premature infant.
Topics: Anti-Bacterial Agents; Exanthema; Humans; Infant, Newborn; Infant, Premature; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Tazobactam | 2008 |